Tahseen Al-Saleem

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. ncbi request reprint Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms
    Tahseen Al-Saleem
    Department of Pathology, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA
    Blood 105:2274-80. 2005
  2. ncbi request reprint Renal oncocytoma with loss of chromosomes Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression?
    Tahseen Al-Saleem
    Department of Pathology, Medical Science Division, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Cancer Genet Cytogenet 163:81-5. 2005
  3. pmc Global reactivation of epigenetically silenced genes in prostate cancer
    Ilsiya Ibragimova
    Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Cancer Prev Res (Phila) 3:1084-92. 2010
  4. ncbi request reprint The genetics of renal oncocytosis: a possible model for neoplastic progression
    Tahseen Al-Saleem
    Department of Pathology, Medical Science Division, Human Genetics Program, Populations Sciences Division, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Cancer Genet Cytogenet 152:23-8. 2004
  5. doi request reprint Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer
    Anna Potapova
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer Res 68:998-1002. 2008
  6. ncbi request reprint Promoter hypermethylation profile of kidney cancer
    Essel Dulaimi
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Clin Cancer Res 10:3972-9. 2004
  7. ncbi request reprint Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients
    Essel Dulaimi
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Clin Cancer Res 10:6189-93. 2004
  8. ncbi request reprint Identification of novel target genes by an epigenetic reactivation screen of renal cancer
    Inmaculada Ibanez de Caceres
    Departments of Surgical Oncology and Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer Res 66:5021-8. 2006
  9. pmc Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate
    Thomas N Eade
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer 109:2011-5. 2007
  10. ncbi request reprint Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel
    Essel Dulaimi
    Departments of Surgical Oncology and Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Clin Cancer Res 10:1887-93. 2004

Collaborators

Detail Information

Publications30

  1. ncbi request reprint Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms
    Tahseen Al-Saleem
    Department of Pathology, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA
    Blood 105:2274-80. 2005
    ..IPSID lymphoma shares clinical, morphologic, and molecular features with MALT lymphoma, lymphoplasmacytic lymphoma, and plasma cell neoplasms...
  2. ncbi request reprint Renal oncocytoma with loss of chromosomes Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression?
    Tahseen Al-Saleem
    Department of Pathology, Medical Science Division, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Cancer Genet Cytogenet 163:81-5. 2005
    ..Conventional cytogenetics and FISH demonstrated loss of chromosomes Y and 1 and gains of chromosome 7. We postulate that the PRCC represents a neoplastic progression by the gain of chromosome 7 oncocytoma with -Y and -1...
  3. pmc Global reactivation of epigenetically silenced genes in prostate cancer
    Ilsiya Ibragimova
    Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Cancer Prev Res (Phila) 3:1084-92. 2010
    ..Further study of the hypermethylome will provide insight into the biology of the disease and facilitate translational studies in prostate cancer...
  4. ncbi request reprint The genetics of renal oncocytosis: a possible model for neoplastic progression
    Tahseen Al-Saleem
    Department of Pathology, Medical Science Division, Human Genetics Program, Populations Sciences Division, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Cancer Genet Cytogenet 152:23-8. 2004
    ..To our knowledge, this is the first report of the genetic and cytogenetic findings in oncocytosis not related to BDH syndrome and may suggest a possible model of progression from oncocytoma to chromophobe renal cell carcinoma...
  5. doi request reprint Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer
    Anna Potapova
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer Res 68:998-1002. 2008
    ....
  6. ncbi request reprint Promoter hypermethylation profile of kidney cancer
    Essel Dulaimi
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Clin Cancer Res 10:3972-9. 2004
    ..To gain insight into the role of epigenetic silencing of tumor suppressor and cancer genes in kidney tumorigenesis, we determined a hypermethylation profile of kidney cancer...
  7. ncbi request reprint Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients
    Essel Dulaimi
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Clin Cancer Res 10:6189-93. 2004
    ..In this study, we examine serum, a more readily accessible bodily fluid known to contain neoplastic DNA from individuals with cancer, for methylation-based detection of breast neoplasia...
  8. ncbi request reprint Identification of novel target genes by an epigenetic reactivation screen of renal cancer
    Inmaculada Ibanez de Caceres
    Departments of Surgical Oncology and Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer Res 66:5021-8. 2006
    ....
  9. pmc Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate
    Thomas N Eade
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer 109:2011-5. 2007
    ..This case series of 6 patients is the first to report the outcome of ductal carcinoma treated with external beam radiotherapy...
  10. ncbi request reprint Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel
    Essel Dulaimi
    Departments of Surgical Oncology and Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Clin Cancer Res 10:1887-93. 2004
    ....
  11. pmc Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma
    Jianming Pei
    Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Genes Chromosomes Cancer 49:610-9. 2010
    ..These findings also suggest that the 5q duplication/3p deficiency resulting from unbalanced 3;5 translocations conveys a proliferative advantage of particular importance in ccRCC tumorigenesis...
  12. pmc Pediatric nodal marginal zone lymphoma may develop in the adult population
    Elena Gitelson
    Department of Medical Oncology, Fox Chase Cancer Center, PA 19111, USA
    Leuk Lymphoma 51:89-94. 2010
    ..Clinically, recognition is important to understand the true incidence of this rare form in the adult population and to avoid unnecessary overtreatment of this indolent form...
  13. ncbi request reprint Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesions
    Hong Wu
    Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Invest Dermatol 121:1522-30. 2003
    ..Our experience demonstrates that flow cytometry can be successfully applied to routine skin biopsies and contributes to the diagnosis and subclassification of cutaneous lymphoid lesions...
  14. ncbi request reprint Gleason scoring at a comprehensive cancer center: what's the difference?
    Natasha C Townsend
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Natl Compr Canc Netw 11:812-9. 2013
    ..74). Changes in GS were common and the GS assigned by a comprehensive cancer center provided better BF risk stratification and prognostication for patients. Changes in GS may impact treatment recommendations in 9% to 26% of patients. ..
  15. ncbi request reprint Metanephric adenofibroma: robotic partial nephrectomy of a large Wilms' tumor variant
    Zachary Piotrowski
    Drexel University College of Medicine, Philadelphia, Pennsylvania, USA
    Can J Urol 17:5309-12. 2010
    ..A case of the rare, benign, Wilms' tumor (WT) variant, metanephric adenofibroma (MAF), is presented...
  16. pmc Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02
    Li Yan Khor
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Clin Cancer Res 13:3585-90. 2007
    ..A follow-up investigation was carried out here in more contemporary high-risk men treated on Radiation Therapy Oncology Group 92-02 with STAD+RT or long-term AD+RT (LTAD+RT)...
  17. ncbi request reprint The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician
    Robert G Uzzo
    Department of Surgical Oncology, Division of Urology, Fox Chase Cancer Center, Temple University School of Medicine, 7701 Burholme Avenue, Room C308, Philadelphia, PA 19111, USA
    Urol Clin North Am 30:423-36. 2003
    ..These studies must be correlated in a rigorous fashion to clinical parameters and outcomes. Progress against this elusive tumor will require a continuous translational dialogue between laboratory and clinical investigators...
  18. doi request reprint Tetanus toxoid reactive lymphadenopathy masquerading as T-cell lymphoma
    Christine K White
    Dept of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Future Oncol 8:631-4. 2012
    ..Better integration of the clinical and pathologic data may have led more rapidly to the final diagnosis. Postvaccination responses can mimic lymphoma...
  19. ncbi request reprint Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland
    Rosalia Viterbo
    Department of Urological Oncology, Fox Chase Cancer Center, Temple University Medical Center, Philadelphia, Pennsylvania 19111, USA
    J Urol 174:446-50. 2005
    ..We compared clinical outcomes of the laparoscopic retroperitoneal approach in patients with prior open abdominal surgery with or without radiation to outcomes in those with no surgical history...
  20. pmc Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10
    Li Yan Khor
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 71:1309-15. 2008
    ....
  21. ncbi request reprint The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer
    David J D'Ambrosio
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Radiat Oncol Biol Phys 67:1082-7. 2007
    ..To investigate the prognostic utility of the proportion of prostate biopsy tissue containing Gleason pattern 4 or 5 (GP4/5) after definitive radiotherapy (RT) for prostate cancer...
  22. pmc Pathologic concordance of sporadic synchronous bilateral renal masses
    Jason Rothman
    Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Urology 72:138-42. 2008
    ....
  23. doi request reprint Cutaneous plasmablastic lymphoma
    Anokhi Jambusaria
    Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Am Acad Dermatol 58:676-8. 2008
    ..We report a case of isolated cutaneous plasmablastic lymphoma occurring in an HIV-positive man with more than 10 years of follow-up...
  24. pmc Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma
    Sunil Saroha
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Urol 189:454-61. 2013
    ..A low absolute lymphocyte count is a likely index of poor systemic immunity that may be associated with aggressive features and inferior survival in patients with clear cell renal cell carcinoma...
  25. pmc Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma
    Vivekanand Gupta
    Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America
    PLoS ONE 6:e21494. 2011
    ..The clinical value of assessing RCC stromal activation merits further study...
  26. doi request reprint Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature
    Danielle Shafer
    Departments of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Arch Dermatol 144:1155-62. 2008
    ..Most reported cases of B-LBL in the skin, a rarity in adults, are manifestations of existing systemic disease...
  27. ncbi request reprint Is there a benefit to frozen section analysis at the time of partial nephrectomy?
    Steven N Sterious
    Department of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, PA 1911, USA
    Can J Urol 20:6778-84. 2013
    ..The utility of frozen section performance during partial nephrectomy (PN) is controversial. We assessed the predictive value of frozen sections on final margin status for patients undergoing PN for localized renal tumors...
  28. ncbi request reprint Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients
    Cristina Battagli
    Departments of Surgical Oncology and Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer Res 63:8695-9. 2003
    ..Methylation-specific PCR may enhance early detection of renal cancer using a noninvasive urine test...
  29. ncbi request reprint MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610
    Li Yan Khor
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer 104:962-7. 2005
    ....
  30. ncbi request reprint Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature
    Kalyani Narra
    Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Leuk Res 30:109-14. 2006
    ..We then review the literature on PRCA in lymphoma and response to rituximab. PRCA associated with CLL or lymphoma may be another indication for rituximab therapy...